Rituximab Plus Cyclophosphamide in Treating Patients With Indolent Stage III or Stage IV Non-Hodgkin's Lymphoma
- Status
- WITHDRAWN
- Phase
- PHASE2
Clinical Trials Related to Rituximab
Related studies linked through entity extraction aliases.
Combination Chemotherapy With or Without Monoclonal Antibody Therapy in Treating Patients With Previously Untreated HIV-Associated Non-Hodgkin's Lymphoma
- Status
- COMPLETED
- Phase
- PHASE3
Rituximab in Treating Patients With Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE2
Peripheral Stem Cell Transplantation Plus Combination Chemotherapy and Monoclonal Antibody Therapy in Treating Patients With Non-Hodgkin's Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Rituximab Plus Interleukin-2 in Treating Patients With Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Monoclonal Antibody Therapy in Treating Patients With Follicular or Mantle Cell Lymphoma
- Status
- COMPLETED
- Phase
- PHASE3
Fludarabine and Monoclonal Antibody Therapy in Treating Patients With Untreated B-cell Chronic Lymphocytic Leukemia
- Status
- COMPLETED
- Phase
- PHASE2
Combination Chemotherapy With or Without Monoclonal Antibody Therapy in Treating Patients With Stage III or Stage IV Low-Grade Non-Hodgkin's Lymphoma
- Status
- COMPLETED
- Phase
- PHASE3
Combination Chemotherapy With or Without Monoclonal Antibody Therapy in Treating Older Patients With Non-Hodgkin's Lymphoma
- Status
- COMPLETED
- Phase
- PHASE3
A Phase II Clinical Trial of Suppression of Human Antimouse Antibody and Human Antitoxin Response to Immunotoxin LMB-1 by Rituximab
- Status
- COMPLETED
- Phase
- PHASE2
Treatment of Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL): DNA Microarray Gene Expression Analysis
- Status
- COMPLETED
- Phase
- PHASE2
EPOCH Chemotherapy +/- IL-12 for Previously Untreated and EPOCH Plus Rituximab for Previously Treated Patients With AIDS-Associated Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Dose-Adjusted EPOCH Chemotherapy and Rituximab (CD20+) in Previously Untreated Aggressive Non-Hodgkin's Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2